JPMORGAN CHASE & CO - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$174,077
-45.4%
51,199
+18.1%
0.00%
Q2 2023$318,549
-56.1%
43,340
-38.1%
0.00%
Q1 2023$726,000
+25073.4%
70,061
-71.3%
0.00%
Q4 2022$2,884
-99.8%
244,243
+287.5%
0.00%
Q3 2022$1,323,000
-74.5%
63,030
-62.3%
0.00%
-100.0%
Q2 2022$5,191,000
-20.4%
167,214
+5.3%
0.00%0.0%
Q1 2022$6,520,000
+213.3%
158,793
+231.6%
0.00%
Q4 2021$2,081,000
-56.2%
47,884
-49.5%
0.00%
-100.0%
Q3 2021$4,751,000
-24.2%
94,887
-4.7%
0.00%0.0%
Q2 2021$6,270,000
-34.5%
99,544
-3.4%
0.00%0.0%
Q1 2021$9,577,000
-41.2%
103,081
-43.3%
0.00%
-50.0%
Q4 2020$16,291,000
-18.3%
181,816
-4.9%
0.00%
-33.3%
Q3 2020$19,939,000
+419.9%
191,094
+294.0%
0.00%
+200.0%
Q2 2020$3,835,000
+191.4%
48,502
+113.1%
0.00%
Q1 2020$1,316,000
+4.4%
22,757
-2.5%
0.00%
Q4 2019$1,260,000
+4.4%
23,343
+1.1%
0.00%
Q3 2019$1,207,000
+7.8%
23,088
-1.1%
0.00%
Q2 2019$1,120,000
+0.4%
23,338
+5.8%
0.00%
Q1 2019$1,115,000
-57.2%
22,066
-49.8%
0.00%
-100.0%
Q4 2018$2,608,000
+47.9%
43,989
+64.3%
0.00%
Q3 2018$1,763,000
+60.1%
26,779
+22.8%
0.00%
Q2 2018$1,101,000
-63.3%
21,799
-61.7%
0.00%
-100.0%
Q1 2018$2,998,000
-18.5%
56,945
-28.1%
0.00%0.0%
Q4 2017$3,679,000
+585.1%
79,155
+486.9%
0.00%
Q3 2017$537,000
+16.0%
13,488
-1.4%
0.00%
Q2 2017$463,000
+20.6%
13,675
+3.3%
0.00%
Q1 2017$384,000
-9.9%
13,233
+2.0%
0.00%
Q4 2016$426,000
-82.8%
12,976
-83.5%
0.00%
-100.0%
Q3 2016$2,482,000
+514.4%
78,700
+447.6%
0.00%
Q2 2016$404,000
-19.7%
14,373
+4.0%
0.00%
Q1 2016$503,000
-39.0%
13,825
-32.9%
0.00%
Q4 2015$824,000
+16.9%
20,616
-16.7%
0.00%
Q3 2015$705,000
-16.7%
24,753
-3.6%
0.00%
Q2 2015$846,000
+30.8%
25,676
+14.1%
0.00%
Q1 2015$647,000
+4.7%
22,500
-0.9%
0.00%
Q4 2014$618,000
+18.8%
22,700
-7.0%
0.00%
Q3 2014$520,0000.0%24,416
+5.7%
0.00%
Q2 2014$520,000
+10.2%
23,104
+23.9%
0.00%
Q1 2014$472,000
-53.8%
18,654
-65.2%
0.00%
Q3 2013$1,021,000
+67.7%
53,620
+27.0%
0.00%
Q2 2013$609,00042,2230.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders